Company
Elanco UK AH Limited
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Elanco UK AH Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 4
- Francois Jean-Noel Emile Vanhersecke 2019-2021 View profile
- Kristina Mary Hunt 2018-2026 View profile
- Peter Troutt 2018-2021 View profile
- Nilesh (Neel) Sukumar Ambani 2018-2018 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- Incorporated
- 23/05/2018
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- ELI Lilly and Company Limited ceased 2019-03-11
75-100% shares, 75-100% voting, appoints directors · notified 2018-05-23
Group
- Elanco UK AH Limited
is controlled by ELI Lilly and Company Limited
Evidence
ceased 75-100% shares, 75-100% voting, appoints directors · notified 2018-05-23, ceased 2019-03-11 · source: Companies House PSC register - ELI Lilly and Company Limited
is controlled by ELI Lilly Group Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors (firm), significant influence (firm) · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by ELI Lilly Group Limited.
23 other companies in this group
- ELI Lilly Property Limited
- ELI Lilly and Company Limited
- ELI Lilly Group Pension Trustees Limited
- Leucid BIO LTD
- Lilly Research Centre Limited
- Lilly Industries Limited
- Sirakoss Limited
- Dista Products Limited
- ELI Lilly Leasing Limited
- Elanco Animal Health UK Limited
- Elanco Europe LTD.
- Lilly Property Limited
- ELI Lilly Resources Limited
- Greenfield Pharmaceuticals Limited
- Vericore Limited
- Elanco Animal Vaccines Limited
- ELI Lilly (Basingstoke) Limited
- ELI Lilly Holding Company Limited
- Lilly Resources Limited
- Edinburgh Molecular Imaging Limited
- Epidarex Capital II, LP
- Caldan Therapeutics Limited
- ELI Lilly Group Limited
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
3 directors on the board
- Matthew Jonathan Frost Director · appointed 2021
- Christopher Lewis Director · appointed 2018
- Nicholas Davis Director · appointed 2025
Directors past 6 years
- Christopher Lewis Director · appointed 2018
First-time vs portfolio directors
First-time (1)
- Nicholas Davis Director · appointed 2025
Portfolio (2)
- Matthew Jonathan Frost Director · appointed 2021
- Christopher Lewis Director · appointed 2018
Left in the last 12 months
- Kristina Mary Hunt Director · appointed 2018 · resigned 2026
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 11378434
- Status
- Active
- Type
- Private Limited Company
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data